30 closest matches · ranked by relevance
Andropause
Primary: Sexual Function Trial - Change in Psychosexual Daily Questionnaire Question 4 (PDQ-Q4) From Baseline to Month 12 — 1.4; 1.4; 0.6; 0.1 units on the PDQ-Q4 scale — p=<0.001
Lung Cancer · Gastric Cancer · Pancreatic Cancer
Primary: Clinical Trials Attitudes, Knowledge, and Interest — 4.6; 3.9; 4.9; 3.7 units on a scale — p=.307
Amyotrophic Lateral Sclerosis · ALS
Primary: Safety Assessment of IFB-088 50 mg/Day in Patients With Bulbar-onset ALS. Number of Participants With Treatment-Emergent Adverse Events [Safety and Tolerability] — 10…
Recruitment
Primary: ACTNOW! Clinical Trial Knowledge Assessment Score — 93.89; 93.58; 94.88; 97.88 score
Idiopathic Pulmonary Fibrosis
Primary: Number of Participants With Adverse Events — 0; 0; 2; 3 Participants
Advanced Solid Tumors
Primary: Pharmacokinetic Analysis: Dose-adjusted AUC(0-∞) — 288.55; 105.8 μg·h/L/mg
Venipuncture · Healthy Adult
Primary: Number of Participants With Successful Venous Catheterization at the First Attempt — 21; 18; 19; 28 Participants — p=0.001
Chronic Obstructive Pulmonary Disease (COPD) · Congestive Heart Failure (CHF) · Sleep Disordered Breathing (SDB)
Primary: Time to First Hospitalization — 255; 224 days — p=0.342
Ovarian Cancer
Primary: Progression-free Survival by Independent Review Committee — 3.5; 3.6 months — p=0.6294
Visual Acuity
Primary: CLUE Vision — 52.77; 52.23 units on a scale
Parkinson Disease · Parkinson's Disease and Parkinsonism
Primary: Change in The International Parkinson and Movement Disorder Society Non-Motor Rating Scale (MDS-NMS) Total Score — -21.2; -18.3 score on a scale
Juvenile Dermatomyositis
Primary: Responder Status Defined as 20% Improvement in at Least 3 Core Set Variables With no More Than 1 of the Remaining Variables, (Muscle Strength Excluded), Worsened by >…
Prostate Cancer
Primary: Number of Participants That Completed All Telemedicine Visits — 12 Participants
Depression
Primary: Change in Depression Symptom Control as Measured by PROMIS (Patient-Reported Outcomes Measurement Information System) — -4.3; -4.0 T-score — p=0.677
Improve the Informed Consent Process
Primary: Quality of Informed Consent Part A (QuIC-A) Score — 81.8; 80.5 units on a scale — p=0.37
Acne
Primary: Percent Change From Baseline in Total Lesions at Week 12 — -17.1; -45.6; -13.0; 7.6 Percent change in lesions
Apheresis Related Hypotension
Primary: Rate of Significant Hypotensive Adverse Events — .035; .051 % of significant hypotensive AEs
Total Knee Arthroplasty
Primary: Mean Triathlon CR Active Range of Motion (ROM) — 112.96 degree
Depression · Acute Pain · Chronic Pain
Primary: Number of Individuals Identified as Potential Participants Through EHR (Electronic Health Record) — 17,496 Participants
Diabetes Mellitus · Type 1 Diabetes · Diabetes Mellitus, Type 1
Primary: HbA1c — 56; 54; 61 mmol/mol — p=<0.001
Growth Disorders
Primary: Subjects' Overall Impression After Using E-Device — 0; 7; 13 subjects
Leucocytosis
Primary: AUC (0-48 Hours) — 168603.588; 181152; 411826.811; 427355.99 picogram per ml / hour
COVID-19
Primary: Time to Recovery — 15; 10 Days — p=<0.001
Psoriasis Vulgaris
Primary: Number of Participants With a Decrease in the Physicians Global Assessment (PGA) Score of Minimum 2 Points on a Scale From 0-4 From Baseline to Week 8 — 121; 67; 4 Count…
Leber Congenital Amaurosis
Primary: Overall Safety of Adeno-Associated Virus Vector (AAV-OPTIRPE65) - Number of Participants With a Safety Event — 0; 0; 1; 0 Participants
Diabetes Mellitus · Cardiovascular Disease
Primary: Adherence to Statins — 0.55; 0.57; 0.58; 0.38 mMPR as a fraction — p=<.001
Treatment Resistant Depression
Primary: Montgomery Asberg Depression Rating Scale (MADRS) 24 Hours — -13.7; -15.3; -13.7 score on a scale
Primary Dental Caries, Multisurface Origin (Diagnosis)
Primary: Fitting — 37; 42; 48; 3 Teeth
Androgenetic Alopecia
Primary: Target Area Hair Count — 152.7; 158.6; 162.2; 175.7 hairs per centimeter squared — p=<0.0001
Alzheimer Disease
Primary: Alzheimer's Disease Assessment Scale-Cognitive Subscale 11 (ADAS-Cog 11) — 23.7; 23.4; 23.6; 26.6 score on a scale — p=<0.0455